Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.
Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, Brun E, Hjorthaug K, Viney ZN, Pike LC, Federico M, Luminari S, Radford J, Trotman J, Fosså A, Berkahn L, Molin D, D'Amore F, Sinclair DA, Smith P, O'Doherty MJ, Stevens L, Johnson PW. Barrington SF, et al. Among authors: molin d, d amore f. Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8. Blood. 2016. PMID: 26747247 Free article.
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
Pedersen MA, Gormsen LC, Kamper P, Wassberg C, Andersen MD, d'Amore AL, Barrington SF, Johnson P, Hamilton-Dutoit S, Amini RM, Enblad G, Molin D, d'Amore F. Pedersen MA, et al. Among authors: d amore al, molin d, d amore f. Br J Haematol. 2019 Aug;186(3):431-439. doi: 10.1111/bjh.15933. Epub 2019 May 22. Br J Haematol. 2019. PMID: 31115045 Free article.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH. Chen R, et al. Among authors: molin d. Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13. Blood. 2019. PMID: 31409671 Free PMC article. Clinical Trial.
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
Hollander P, Kamper P, Smedby KE, Enblad G, Ludvigsen M, Mortensen J, Amini RM, Hamilton-Dutoit S, d'Amore F, Molin D, Glimelius I. Hollander P, et al. Among authors: molin d, d amore f. Blood Adv. 2017 Aug 8;1(18):1427-1439. doi: 10.1182/bloodadvances.2017006346. eCollection 2017 Aug 8. Blood Adv. 2017. PMID: 29296784 Free PMC article.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D. Lagerlöf I, et al. Among authors: molin d. Br J Haematol. 2020 Mar;188(5):685-691. doi: 10.1111/bjh.16232. Epub 2019 Oct 14. Br J Haematol. 2020. PMID: 31612478 Free article. Clinical Trial.
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087. Chen R, et al. Among authors: molin d. J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25. J Clin Oncol. 2017. PMID: 28441111 Free PMC article. Clinical Trial.
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Jakobsen LH, Hutchings M, de Nully Brown P, Linderoth J, Mylam KJ, Molin D, Johnsen HE, Bøgsted M, Jerkeman M, El-Galaly TC. Jakobsen LH, et al. Among authors: molin d. Br J Haematol. 2016 Apr;173(2):236-44. doi: 10.1111/bjh.13943. Epub 2016 Feb 5. Br J Haematol. 2016. PMID: 26846879 Free article.
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.
Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S. Vajavaara H, et al. Among authors: molin d, d amore f. Haematologica. 2021 Sep 1;106(9):2502-2506. doi: 10.3324/haematol.2020.278182. Haematologica. 2021. PMID: 33764002 Free PMC article. No abstract available.
151 results